[HTML][HTML] The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li, Z Peng - Critical Care, 2023 - Springer
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials.
F Wang, Y Li, B Wang, J Li, Z Peng - Critical Care, 2023 - search.ebscohost.com
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
[HTML][HTML] The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li, Z Peng - Critical Care, 2023 - journalwise.acponline.org
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
[HTML][HTML] The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li, Z Peng - Critical Care, 2023 - ncbi.nlm.nih.gov
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li… - Critical care (London …, 2023 - pubmed.ncbi.nlm.nih.gov
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
[PDF][PDF] The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li, Z Peng - 2023 - scienceopen.com
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
[引用][C] The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li, Z Peng - 2023 - europepmc.org
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li, Z Peng - Critical Care, 2023 - search.proquest.com
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
[HTML][HTML] The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
F Wang, Y Li, B Wang, J Li, Z Peng - Critical Care, 2023 - ccforum.biomedcentral.com
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials.
F Wang, Y Li, B Wang, J Li, Z Peng - Critical Care, 2023 - go.gale.com
Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …
trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 …